Keystone Financial Group (Kentucky)’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.5K | Hold |
|
|||||
|
2025
Q1 | $16.4K | Hold |
|
|||||
|
2024
Q4 | $18.4K | Hold |
|
|||||
|
2024
Q3 | $58.2K | Sell |
|
|||||
|
2024
Q2 | $81.5K | Sell |
|
|||||
|
2024
Q1 | $143K | Buy |
|
|||||
|
2023
Q4 | $62.6K | Buy |
|
|||||
|
2023
Q3 | $42.8K | Buy |
|
|||||
|
2023
Q2 | $47.5K | Buy |
|
|||||
|
2022
Q4 | $155K | Buy |
|
|||||
|
2022
Q3 | $128K | Sell |
|
|||||
|
2022
Q2 | $128K | Buy |
|
|||||
|
2022
Q1 | $260K | Buy |
|
|||||
|
2021
Q4 | $331K | Buy |
|
|||||
|
2021
Q3 | $452K | Buy |
|
|||||
|
2021
Q2 | $563K | Buy |
|
|||||
|
2021
Q1 | $522K | Buy |
|
|||||
|
2020
Q4 | $346K | Buy |
|
|||||
|
2020
Q3 | $377K | Buy |
|